TCL1A and leukemia: Similarly, we showed that PAX5, EBF1, CD72 and TCL1A are tightly correlated in the capacity to distinguish lymphoblastic and myeloblastic characteristics also in the presence of MLL mutations illustrating the importance of B-cell receptor signaling pathway in this subset of leukemias.